Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yang, Diane ^a   Scavuzzo, Marissa A ^a   Chmielowiec, Jolanta ^a,b   Sharp, Robert ^a,b   Bajic, Aleksandar ^d   Borowiak, Malgorzata ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c McNair Medical Institute   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE G2 PHASE; CELL DIVISION; CELL LINE; CRISPR CAS SYSTEM; CYTOLOGY; GENE TARGETING; HUMAN; METABOLISM; PLURIPOTENT STEM CELL; PROCEDURES; RECOMBINATION REPAIR;

CELL DIVISION; CELL LINE; CRISPR-CAS SYSTEMS; G2 PHASE; GENE TARGETING; HUMANS; PLURIPOTENT STEM CELLS; RECOMBINATIONAL DNA REPAIR;

EID: 84959141422     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21264     Document Type: Article

References (51)

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-72 (2007).
2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-20 (2007).
3. Thomas, K. R. & Capecchi, M. R. Targeting of genes to specific sites in the mammalian genome. Cold Spring Harb Symp Quant Biol 51 (Pt 2), 1101-13 (1986).
4. Thomas, K. R., Folger, K. R. & Capecchi, M. R. High frequency targeting of genes to specific sites in the mammalian genome. Cell 44, 419-28 (1986).
5. Capecchi, M. R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6, 507-12 (2005).
6. Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21, 319-21 (2003).
7. Hockemeyer, D. & Jaenisch, R. Gene targeting in human pluripotent cells. Cold Spring Harb Symp Quant Biol 75, 201-9 (2010).
8. Merkle, F. T. et al. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep 11, 875-83 (2015).
9. Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25, 1298-306 (2007).
10. Zou, J. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97-110 (2009).
11. Hockemeyer, D. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29, 731-4 (2011).
12. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370-9 (2013).
13. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910-8 (2013).
14. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-21 (2012).
15. Heyer, W. D., Ehmsen, K. T. & Liu, J. Regulation of homologous recombination in eukaryotes. Annu Rev Genet 44, 113-39 (2010).
16. Koledova, Z., Kramer, A., Kafkova, L. R. & Divoky, V. Cell-cycle regulation in embryonic stem cells: centrosomal decisions on selfrenewal. Stem Cells Dev 19, 1663-78 (2010).
17. Di Domenico, A. I., Christodoulou, I., Pells, S. C., McWhir, J. & Thomson, A. J. Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange. Cloning Stem Cells 10, 217-30 (2008).
18. Yu, C. et al. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell 16, 142-7 (2015).
19. Maruyama, T. et al. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol 33, 538-42 (2015).
20. Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife 3, e04766 (2014).
21. Chu, V. T. et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33, 543-8 (2015).
22. Tsakraklides, V., Brevnova, E., Stephanopoulos, G. & Shaw, A. J. Improved Gene Targeting through Cell Cycle Synchronization. PLoS One 10, e0133434 (2015).
23. Vasquez, R. J., Howell, B., Yvon, A. M., Wadsworth, P. & Cassimeris, L. Nanomolar Concentrations of Nocodazole Alter Microtubule Dynamic Instability In Vivo and In Vitro. Mol Biol Cell 8, 973-85 (1997).
24. Hande, K. R. et al. The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 study. Clin Cancer Res 12, 2834-40 (2006).
25. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-7 (1998).
26. Cowan, C. A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350, 1353-6 (2004).
27. Maehr, R. et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106, 15768-73 (2009).
28. Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487-98 (2008).
29. Singh, A. M. et al. Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Reports 1, 532-44 (2013).
30. Pauklin, S. & Vallier, L. The cell-cycle state of stem cells determines cell fate propensity. Cell 155, 135-47 (2013).
31. Mao, Z., Bozzella, M., Seluanov, A. & Gorbunova, V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst) 7, 1765-71 (2008).
32. Adams, B. R., Hawkins, A. J., Povirk, L. F. & Valerie, K. ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY) 2, 582-96 (2010).
33. Hou, Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA 110, 15644-9 (2013).
34. Roccio, M. et al. Predicting stem cell fate changes by differential cell cycle progression patterns. Development 140, 459-70 (2013).
35. Chetty, S. et al. A simple tool to improve pluripotent stem cell differentiation. Nat Methods 10, 553-6 (2013).
36. Kannagi, R. et al. Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2, 2355-61 (1983).
37. Scholer, H. R., Ruppert, S., Suzuki, N., Chowdhury, K. & Gruss, P. New type of POU domain in germ line-specific protein Oct-4. Nature 344, 435-9 (1990).
38. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-56 (2005).
39. Kim, J., Chu, J., Shen, X., Wang, J. & Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-61 (2008).
40. Levine, A. J. & Brivanlou, A. H. GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133, 209-16 (2006).
41. Richards, M., Tan, S. P., Tan, J. H., Chan, W. K. & Bongso, A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 51-64 (2004).
42. Lee, C. S., Friedman, J. R., Fulmer, J. T. & Kaestner, K. H. The initiation of liver development is dependent on Foxa transcription factors. Nature 435, 944-7 (2005).
43. Arceci, R. J., King, A. A., Simon, M. C., Orkin, S. H. & Wilson, D. B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 13, 2235-46 (1993).
44. Nair, S. & Schilling, T. F. Chemokine signaling controls endodermal migration during zebrafish gastrulation. Science 322, 89-92 (2008).
45. Kanai-Azuma, M. et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129, 2367-79 (2002).
46. Faial, T. et al. Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells. Development 142, 2121-35 (2015).
47. Lyons, I. et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9, 1654-66 (1995).
48. Li, H. S., Yang, J. M., Jacobson, R. D., Pasko, D. & Sundin, O. Pax-6 is first expressed in a region of ectoderm anterior to the early neural plate: implications for stepwise determination of the lens. Dev Biol 162, 181-94 (1994).
49. Pevny, L. H., Sockanathan, S., Placzek, M. & Lovell-Badge, R. A role for SOX1 in neural determination. Development 125, 1967-78 (1998).
50. Serrano, L. et al. Homologous recombination conserves DNA sequence integrity throughout the cell cycle in embryonic stem cells. Stem Cells Dev 20, 363-74 (2011).
51. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-23 (2013).